Cancer Incidence and Mortality among White Individuals, Suffolk County, 2016-2020

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males and Females Males Females Males and Females Males Females
Average Annual Cases Rate per 100,000 Population 95% CI Average Annual Cases Rate per 100,000 Males 95% CI Average Annual Cases Rate per 100,000 Females 95% CI Average Annual Deaths Rate per 100,000 Population 95% CI Average Annual Deaths Rate per 100,000 Males 95% CI Average Annual Deaths Rate per 100,000 Females 95% CI
All Invasive Malignant Tumors 9,052.4 528.2 523.1-533.2 4,603.8 578.3 570.6-586.0 4,448.6 496.0 489.2-502.9 2,452.2 137.3 134.8-139.8 1,224.2 157.6 153.6-161.6 1,228.0 123.6 120.4-126.9
Oral cavity and pharynx 218.0 12.4 11.6-13.1 150.2 18.2 16.9-19.6 67.8 7.3 6.5-8.2 34.0 2.0 1.7-2.3 23.0 2.9 2.4-3.5 11.0 1.2 0.9-1.6
Esophagus 84.2 4.6 4.1-5.1 66.2 7.9 7.0-8.8 18.0 1.8 1.4-2.2 66.2 3.6 3.2-4.0 52.4 6.3 5.5-7.1 13.8 1.4 1.1-1.8
Stomach 130.6 7.5 6.9-8.1 76.2 9.5 8.6-10.6 54.4 5.9 5.2-6.7 47.2 2.6 2.3-3.0 25.0 3.1 2.6-3.7 22.2 2.3 1.9-2.8
Colorectal 670.8 39.2 37.8-40.6 356.0 45.5 43.3-47.7 314.8 34.0 32.3-35.8 206.2 11.7 11.0-12.5 107.4 14.1 12.9-15.4 98.8 9.8 8.9-10.8
Colon excluding rectum 480.2 28.0 26.9-29.2 242.6 31.2 29.4-33.1 237.6 25.3 23.9-26.9 164.6 9.3 8.7-10.0 83.4 11.0 9.9-12.1 81.2 8.1 7.3-8.9
Rectum & rectosigmoid 190.6 11.2 10.4-11.9 113.4 14.2 13.1-15.5 77.2 8.6 7.8-9.6 41.6 2.4 2.1-2.7 24.0 3.2 2.6-3.8 17.6 1.8 1.4-2.2
Liver / intrahepatic bile duct 135.2 7.4 6.9-8.0 95.0 11.4 10.4-12.5 40.2 4.2 3.6-4.8 84.8 4.7 4.2-5.1 56.0 6.8 6.1-7.7 28.8 2.9 2.4-3.4
Pancreas 287.2 16.1 15.3-17.0 144.8 17.9 16.6-19.3 142.4 14.5 13.4-15.6 205.6 11.5 10.8-12.2 102.2 12.8 11.7-14.0 103.4 10.3 9.5-11.3
Larynx 53.6 2.9 2.6-3.3 43.0 5.2 4.5-6.0 10.6 1.1 0.8-1.4 14.4 0.8 0.6-1.0 11.0 1.4 1.0-1.8 3.4 0.3 0.2-0.5
Lung and bronchus 1,170.6 65.1 63.4-66.8 534.2 67.3 64.8-70.0 636.4 64.2 62.0-66.5 554.6 30.8 29.6-32.0 268.6 34.3 32.5-36.3 286.0 28.4 26.9-29.9
Melanoma of the skin 459.8 27.1 25.9-28.2 275.6 35.1 33.2-37.0 184.2 21.2 19.8-22.7 37.0 2.1 1.8-2.4 24.4 3.1 2.5-3.7 12.6 1.3 1.0-1.7
Female breast             1,220.2 140.5 136.8-144.3             172.6 17.7 16.5-19.0
Cervix uteri             39.8 5.6 4.8-6.4             12.0 1.5 1.2-2.0
Corpus uterus and NOS             302.6 31.9 30.3-33.7             53.6 5.5 4.8-6.2
Ovary             109.6 12.4 11.3-13.5             67.6 6.8 6.0-7.6
Prostate       1,145.6 133.5 130.0-137.1             113.0 15.1 13.9-16.4      
Testis       46.2 8.0 7.0-9.2             2.2 0.3 0.2-0.6      
Urinary bladder (incl. in situ) 495.0 27.9 26.8-29.1 369.8 47.6 45.4-49.9 125.2 12.7 11.7-13.7 88.8 4.9 4.5-5.4 63.6 8.6 7.7-9.6 25.2 2.4 2.0-2.8
Kidney and renal pelvis 329.6 19.2 18.3-20.2 210.4 26.3 24.7-28.0 119.2 13.0 11.9-14.1 47.4 2.6 2.3-3.0 30.8 3.9 3.3-4.6 16.6 1.6 1.3-2.0
Brain and other central nervous system 112.8 7.4 6.8-8.1 60.0 8.3 7.3-9.3 52.8 6.7 5.9-7.6 75.2 4.4 3.9-4.8 43.0 5.3 4.6-6.2 32.2 3.5 2.9-4.1
Thyroid 304.6 22.1 21.0-23.3 95.4 13.1 11.9-14.4 209.2 31.2 29.2-33.2 10.4 0.6 0.4-0.8 3.8 0.5 0.3-0.8 6.6 0.7 0.5-1.0
Hodgkin lymphoma 48.4 3.7 3.2-4.2 25.2 3.8 3.1-4.5 23.2 3.6 3.0-4.4 4.4 0.3 0.2-0.5 2.0 0.3 0.1-0.6 2.4 0.3 0.2-0.6
Non-Hodgkin lymphomas 391.2 23.1 22.0-24.1 212.8 27.6 25.9-29.4 178.4 19.5 18.2-20.9 83.0 4.6 4.2-5.1 46.8 6.1 5.3-6.9 36.2 3.6 3.1-4.2
Myeloma 138.8 7.9 7.3-8.5 80.6 10.0 9.1-11.1 58.2 6.1 5.4-6.9 43.8 2.4 2.1-2.7 25.4 3.2 2.6-3.8 18.4 1.7 1.4-2.2
Leukemias 332.4 20.1 19.1-21.1 197.4 26.2 24.5-27.9 135.0 15.2 14.0-16.4 101.4 5.9 5.3-6.4 59.6 8.0 7.1-9.0 41.8 4.3 3.7-4.9

Notes

  • Incidence data are provisional, November 2022.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.
  • NYSCR mortality statistics might differ slightly from official mortality statistics due to the availability of additional demographic information.